Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033774 (
pruritus
)
14,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chronic renal failure, regardless of its cause, often produces specific dermatological abnormalities, which can develop long before failure manifests clinically. Our aim was to study the clinical pattern of skin and nail changes in
chronic renal failure
and also study the associations of these changes with age, sex, etiology and duration of the
chronic renal failure
. A total of 104 diagnosed cases of
chronic renal failure
were included in the study over a period of 1 year. Equal numbers of age- and sex-matched individuals were taken as controls. The male : female ratio was 1.4:1. The mean duration of
chronic renal failure
was 19 +/- 20 months. Among cases and controls, 72% and 16% had skin changes, respectively. Xerosis was the most common of the skin changes (28%), followed by hyperpigmentation (20%),
pruritus
(15%), infectious diseases (5%) and other skin changes (33%) in
chronic renal failure
patients. Abnormal nail changes were seen in 82% of the cases compared to only 8% of the controls. In the cases, white nail was most common followed by brown and half-and-half nail.
Pruritus
was significantly higher in the dialysis group whereas the nail changes were significantly higher in the non-dialysis group. The skin and nail changes were common in
chronic renal failure
and manifested in various forms. Thus, thorough inspection of the integument might reveal markers of occult renal disease.
...
PMID:Pattern of skin and nail changes in chronic renal failure in Nepal: a hospital-based study. 1834 56
Itch
is a common symptom in dry skin related to inflammatory skin diseases, normal aging, and systemic diseases such as
chronic renal failure
, and HIV. However, correlations between
itch
and objective measures of barrier function and skin dryness such as skin hydration and transepidermal water loss have been rarely found. Recent experimental evidence indicates that damage to the stratum corneum with acetone/ether and water elicits a scratching response in mice and rats. These responses correlate to the number of PGP 9.5 immunoreactive fibers in the epidermis and to FOS-like immunoreactivity in the spinal cord. Other neuromediators involved in the pathogenesis of
itch
in dry skin are nerve growth factor (NGF), muscarinic acetylcholine receptors, and opiates. Serine proteases such as tryptase and their respective proteinase-activating receptor 2 (PAR2), recently found in both skin and nerves of patients with atopic eczema, suggest that these molecules may have a role in
itch
in dry skin. This has also been exemplified in the itchy and hyperkeratotic phenotype of the stratum corneum chymotryptic enzyme (SCCE) transgenic mouse model, which is over-expressing a serine protease. Developing inhibitors to these neuropeptides and mediators may be an attractive strategy for anti-
itch
treatment. The significant progress made in development of moisturizers may have an additional benefit in reducing the
itch
associated with dry skin. Formulating topical combination therapies containing moisturizers and anti-pruritics can significantly reduce the
itch
associated with dry skin. This paper will review the current clinical knowledge on the association between dry skin and
itch
and the recent advances in understanding the pathophysiology of this problem.
...
PMID:Dry skin and impairment of barrier function associated with itch - new insights. 1849 19
Uremic
pruritus
is a common and sometimes severe complication of
chronic renal failure
.
Itch
affects 50-90% of patients undergoing peritoneal dialysis or hemodialysis and 25% of patients with preterminal
chronic renal failure
. The mechanism underlying uremic
pruritus
is poorly understood; possibilities include histamin, proteases, interleukin-2 and TNF- produced by skin mast-cells, substance P, neuropathy and neurological changes, high level of Ca, P, PTH, Al, Mg, divalent ion abnormalities, hypervitaminosis A, inflammation, or some combination of these. Therapeutic measures include regular efficient dialysis, transplantation, topical measures as an emollients, topical steroids, systemic measures as diet, opioids and physical treatment with phototherapy, acupuncture etc. Treatment results are highly variable and more research is needed to understand the patophysiology of this condition and to establish more reliable treatments. Most effective treatments in this moment are efficient dialysis, dietary restrictions, phosphate-binding therapy and phototherapy.
...
PMID:[Uremic pruritus]. 1857 30
Magnesium (Mg) is the fourth most abundant cation in the body, mainly located within bone and skeletal muscle. The normal total plasma Mg concentration varies in a narrow range, with approximately 60% present as free Mg ions, the biologically active form. The kidney plays a principal role in Mg balance. Approximately 70-80% of plasma Mg is ultrafilterable, and under normal circumstances, 95% of the filtered load of Mg is reabsorbed. As
chronic renal failure
(
CRF
) progresses, urinary Mg excretion may be insufficient to balance intestinal Mg absorption and dietary Mg intake becomes a major determinant of serum and total body Mg levels. Until severe reductions in glomerular filtration rate (<30 ml/min), serum Mg levels are usually normal; with lower rates of renal function, serum Mg is increased. Concerning dialysis patients, dialysate Mg plays a critical role in maintaining Mg homeostasis, with serum Mg being largely dependent on the concentration of the ion in the dialysis solution. Magnesium has been implicated in diverse consequences, both beneficial and deleterious, in patients with
CRF
and dialysis. Potential harmful effects of elevated Mg include altered nerve conduction velocity, increased
pruritus
, and alterations to osseous metabolism and parathyroid gland function (mineralization defects, contribution to osteomalacic renal osteodystrophy, and adynamic bone disease). Hypermagnesemia also may retard vascular calcification. Low Mg levels have been associated with impairment of myocardial contractility, intradialytic hemodynamic instability, and hypotension. In addition, low Mg has been also linked to carotid intima-media thickness, a marker of atherosclerotic vascular disease and a predictor of vascular events.
...
PMID:Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. 1925 Apr 45
Nephrogenic systemic fibrosis is a highly debilitating and emotionally depressing disorder. So far, it has exclusively occurred in patients suffering from acute or
chronic renal failure
. Most patients had been exposed to gadolinium- based contrast agents. Early symptoms include pain, swelling and
pruritus
, predominantly of the extremities. Fibrosis of the skin and other organs develops in the further course of the disease. The diagnosis is made based on the synopsis of medical history, clinical and dermatohistological findings. To avoid the application of gadolinium-based contrast agents in patients with highly impaired renal function is the best measure to prevent the disease. An effective therapy has not yet been established. Possible therapies, which have been successful in individual cases, comprise, among others, a quick restoration of renal function, physiotherapy, and extracorporeal photopheresis.
...
PMID:[Nephrogenic systemic fibrosis]. 1933 10
The classic hallmark symptoms of advanced nephrogenic systemic fibrosis (NSF) (skin thickening, hardening and hyperpigmentation, and disabling contractures in renal failure patients) in temporal association with Gd-based contrast agent (GBCA) exposure are almost pathognomonic of NSF. Less obvious cases may be diagnosed on the basis of history of early GBCA-related NSF symptoms (warm swellings, pain, discoloration,
itching
of lower legs), signs of multiorgan involvement (lungs, nervous system), the exclusion of differential diagnoses, including scleromyxedema and systemic sclerosis, and the histology of deep skin biopsies. Symptomatic treatment with intensive physiotherapy and painkillers is important, but there is no known curative medical treatment. Spontaneous remission of NSF symptoms may occur with recovery of renal function after an episode of acute renal failure, or with kidney transplantation of
chronic renal failure
patients.
...
PMID:Nephrogenic systemic fibrosis: clinical picture and treatment. 1974 98
Classification of
itch
into four categories-pruritoceptive, neurogenic, neuropathic, and psychogenic-has proven to be of utility to clinicians and investigators.
Itch
is recognized to be transmitted by dedicated afferent neurons, and a matrix of cerebral cortical loci involved in perception and the desire to scratch has been recognized. This highlights the multidimensional nature of the
itch
sensation. Some of the many mediators of
itch
, especially relevant in pruritogenic
itch
, are the result of cross-talk between dermal mast cells and adjacent cutaneous afferents. Keratinocytes of the epidermis express many neuropeptides, and their receptors are far from passive bystanders in the neurophysiology of
itch
. Mediators can also act centrally (eg, opioid peptides that act on micro receptors in the central nervous system). The pathophysiology of
pruritus
in neurogenic
itch
caused by common systemic diseases is gradually being elucidated, especially in the
itch
of cholestasis, although the molecular basis of
itching
in
chronic renal failure
remains elusive. Better understanding of the mediators of
itch
and their receptors has led to the imminent development of novel anti-
itch
compounds, including interleukin-31 inhibitors, histamine H4-receptor antagonists, and neurokinin-1 receptor antagonists.
...
PMID:Pathogenesis and treatment of pruritus. 2042 77
Chronic
pruritus
is a major and distressing symptom of many cutaneous and systemic diseases and can significantly impair the patient's quality of life.
Pruritus
perception is the final result of a complex network involving dedicated nerve pathways and brain areas, and an increasing number of peripheral and central mediators are thought to be involved.
Itch
is associated with most cutaneous disorders and, in these circumstances, its management overlaps with that of the skin disease.
Itch
can also occur without associated skin diseases or primary skin lesions, but only with nonspecific lesions secondary to rubbing or scratching. Chronic
itch
with no or minimal skin changes can be secondary to important diseases, such as neurologic disorders,
chronic renal failure
, cholestasis, systemic infections, malignancies, and endocrine disorders, and may also result from exposure to some drugs. The search for the cause of
pruritus
usually requires a meticulous step-by-step assessment involving careful history taking as well as clinical examination and laboratory investigations. Few evidence-based treatments for
pruritus
are available. Topical therapy, oral histamine H(1) receptor antagonists, and phototherapy with UV radiation can target
pruritus
elicitation in the skin, whereas antiepileptic drugs, opioid receptor antagonists, and antidepressants can block signal processing in the CNS.
...
PMID:Chronic pruritus in the absence of specific skin disease: an update on pathophysiology, diagnosis, and therapy. 2086 15
Dermatological manifestations of
chronic renal failure
were studied in 35 cases. Xerosis was seen in 16 cases.
Pruritus
was observed in 12 cases and hyperpigmentation on exposed areas was seen in 8 patients. Acquired perforating disorder and half and half nail were seen in 6 cases each. Skin Biopsies performed in 6 cases of APD showed typical changes only in 3 cases.
...
PMID:Dermatological manifestations of chronic renal failure. 2094 20
Acquired reactive perforating collagenosis is a perforating dermatosis characterized by transepidermal elimination of collagen. It is frequently associated to diabetes mellitus and chronic renal insufficiency, but it is also related to other systemic diseases. The lesions tend to resolve once the underlying condition is treated. We report two patients with the condition. A 65 year-old diabetic female on hemodialysis consulted for multiple
itching
cutaneous ulcers lasting one year. On physical examination, hyperpigmented papules and nodules were observed. A 65 year-old female with
chronic renal failure
in hemodialysis consulted for
itching
lesions in hands, forearms and arms. On physical examination, hyperpigmented lesions with ulcers, erosions and crusts were observed. In both cases, the pathological study of the lesions disclosed a reactive perforating collagenosis.
...
PMID:[Acquired reactive perforating collagenosis: report of two cases]. 2127 76
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>